secwatch / observer
8-K filed April 7, 2026, 7:59 PM ET ticker ANIP CIK 0001023024
other material confidence high sentiment neutral materiality 0.55

ANI PHARMACEUTICALS INC (ANIP): auditor change — ANI Pharmaceuticals dismisses EisnerAmper, appoints Ernst & Young as auditor

ANI PHARMACEUTICALS INC

item 4.01item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ANI PHARMACEUTICALS INC dismissed EisnerAmper LLP as its auditor.

Action
dismissal
Auditor
EisnerAmper LLP
Successor
Ernst & Young LLP
Exact text from the filing
On April 1, 2026, ANI Pharmaceuticals, Inc. (the “Company”) notified EisnerAmper LLP (“EisnerAmper”) that EisnerAmper would be dismissed as the Company’s independent registered public accounting firm.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ANI PHARMACEUTICALS INC engaged Ernst & Young LLP as its auditor.

Action
engagement
Auditor
Ernst & Young LLP
Exact text from the filing
On April 1, 2026, the Audit Committee approved the appointment of Ernst & Young LLP (“EY”), effective April 1, 2026, as the Company’s new independent registered public accounting firm for the fiscal year ended December 31, 2026.
View on SEC.gov

Browse all auditor changes →

ANI PHARMACEUTICALS INC filing history →

Source: SEC EDGAR
accession 0001023024-26-000034
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.